{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:16:47Z","timestamp":1771013807253,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.contraception.2006.03.009","type":"journal-article","created":{"date-parts":[[2006,5,3]],"date-time":"2006-05-03T12:50:35Z","timestamp":1146660635000},"page":"31-35","source":"Crossref","is-referenced-by-count":31,"title":["Studies on uterine contractility following mifepristone and various routes of misoprostol"],"prefix":"10.1016","volume":"74","author":[{"given":"Kristina","family":"Gemzell-Danielsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Bygdeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Aronsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2006.03.009_bib1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0002-9378(73)90517-6","article-title":"Effects of luteectomy and progesterone replacement therapy in early pregnant patients","volume":"115","author":"Csapo","year":"1973","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.contraception.2006.03.009_bib2","first-page":"33","article-title":"Prostaglandin impact inverted question mark for menstrual induction","author":"Csapo","year":"1974","journal-title":"Popul Rep G"},{"key":"10.1016\/j.contraception.2006.03.009_bib3","first-page":"293","article-title":"Medical methods to terminate early pregnancy","volume":"Vol. 4 (2)","author":"Swahn","year":"1990"},{"key":"10.1016\/j.contraception.2006.03.009_bib4","first-page":"933","article-title":"Effect d'un steroid anti-progesteron chez la femme; interruption du cycle menstruel et de la grossess au debut","volume":"294","author":"Herrman","year":"1982","journal-title":"C R Acad Sci (Paris)"},{"key":"10.1016\/j.contraception.2006.03.009_bib5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0010-7824(84)90014-3","article-title":"Termination of early pregnancy by RU 486 \u2014 an antiprogestional compound","volume":"29","author":"Kovacs","year":"1984","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.03.009_bib6","series-title":"Oxford reviews of reproductive biology","first-page":"1","article-title":"Antiprogestational steroids: a new dimension in human fertility regulation","author":"Van Look","year":"1989"},{"key":"10.1016\/j.contraception.2006.03.009_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0010-7824(85)90115-5","article-title":"Progesterone receptor blockage. Effect on uterine contractility and early pregnancy","volume":"32","author":"Bygdeman","year":"1985","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.03.009_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1471-0528.1988.tb06840.x","article-title":"The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin","volume":"95","author":"Swahn","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2006.03.009_bib9","first-page":"436","article-title":"Control of myometrial contractility: role and regulation of gap junctions","volume":"10","author":"Garfield","year":"1988","journal-title":"Oxf Rev Reprod Biol"},{"key":"10.1016\/j.contraception.2006.03.009_bib10","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/0140-6736(91)92102-8","article-title":"Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone","volume":"338","author":"Norman","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2006.03.009_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0010-7824(86)90055-7","article-title":"Therapeutic abortion in early pregnancy with antiprogestogen RU 486 alone or in combination with a prostaglandin analogue (gemeprost)","volume":"34","author":"Cameron","year":"1986","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.03.009_bib12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/00016349209021052","article-title":"Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue","volume":"71","author":"Ulmann","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2006.03.009_bib13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1471-0528.1990.tb02516.x","article-title":"The efficacy and tolerance of mifepristone and prostaglandin in first trimester of pregnancy","volume":"97","author":"UK Multicentre Trial","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2006.03.009_bib14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/bmj.307.6903.532","article-title":"Termination of pregnancy with reduced doses of mifepristone","volume":"307","author":"World Health Organization","year":"1993","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2006.03.009_bib15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/oxfordjournals.humrep.a137420","article-title":"Uterine activity and decidual prostaglandin production in women in early pregnancy in response to mifepristone with or without indomethacin in vivo","volume":"6","author":"Norman","year":"1991","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2006.03.009_bib16","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJM199305273282101","article-title":"Early pregnancy interruption with RU 486 (mifepristone) and misoprostol, an orally active prostaglandin analogue","volume":"328","author":"Peyron","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2006.03.009_bib17","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM199504133321502","article-title":"Induction of abortion with mifepristone (RU 486) and oral and vaginal misoprostol","volume":"332","author":"El-Refaey","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2006.03.009_bib18","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/oxfordjournals.humrep.a138287","article-title":"The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol","volume":"8","author":"McKinley","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2006.03.009_bib19","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S1470-0328(03)02430-3","article-title":"WHO Research Group on Post-Ovulatory Methods for Fertility Regulation. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. Part 1: efficacy","volume":"110","author":"von Hertzen","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2006.03.009_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0029-7844(97)00111-7","article-title":"Absorption kinetics of misoprostol with oral or vaginal administration","volume":"90","author":"Zieman","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2006.03.009_bib21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/humrep\/17.2.332","article-title":"Pharmacokinetics of different routes of administration of misoprostol","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2006.03.009_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0029-7844(98)00436-0","article-title":"Comparison between oral and vaginal administration of misoprostol on uterine contractility","volume":"93","author":"Gemzell-Danielsson","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2006.03.009_bib23","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1749-6632.1959.tb44593.x","article-title":"Oxytocin and contractility of the human pregnant uterus","volume":"75","author":"Caldeyro-Barcia","year":"1959","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.contraception.2006.03.009_bib24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0029-7844(97)00419-5","article-title":"Vaginal misoprostol compared with oral misoprostol in termination of second trimester pregnancy","volume":"90","author":"Ho","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2006.03.009_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0010-7824(01)00261-X","article-title":"Pilot study on the use of sublingual misoprostol for medical abortion","volume":"64","author":"Tang","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.03.009_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/humrep\/deh005","article-title":"Effects of misoprostol on uterine contractility following different routes of administration","volume":"19","author":"Aronsson","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2006.03.009_bib27","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1471-0528.2004.00222.x","article-title":"A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy","volume":"111","author":"Tang","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2006.03.009_bib28","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1001\/jama.284.15.1948","article-title":"Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial","volume":"284","author":"Schaff","year":"2000","journal-title":"JAMA"},{"issue":"5 Pt 1","key":"10.1016\/j.contraception.2006.03.009_bib29","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/01.AOG.0000124271.23499.84","article-title":"MOD Study Trial Group. A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion","volume":"103","author":"Creinin","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2006.03.009_bib30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2307\/2136257","article-title":"Acceptability of medical abortion in early pregnancy","volume":"185","author":"Winikoff","year":"1995","journal-title":"Fam Plann Perspect"},{"key":"10.1016\/j.contraception.2006.03.009_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1447-0756.1984.tb00698.x","article-title":"Termination of pregnancy by a slow release device containing 16, 16-dimethyl-trans-delta 2 PGE1 methyl ester","volume":"10","author":"Bygdeman","year":"1984","journal-title":"Asia Oceania J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2006.03.009_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0010-7824(86)90078-8","article-title":"A controlled release form of 16,16-dimethyl-trans-delta 2-PGE, methyl ester for early abortion","volume":"33","author":"Cameron","year":"1986","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.03.009_bib33","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/humrep\/dei102","article-title":"Effects of slow release misoprostol on uterine contractility in early pregnancy","volume":"20","author":"Fiala","year":"2005","journal-title":"Hum Reprod"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782406000795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782406000795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T15:13:41Z","timestamp":1555600421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782406000795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0010782406000795"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2006.03.009","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}